Clemens W.G.M. Löwik

Erasmus MC Cancer Institute — Netherlands

Medicine · Health Sciences

85h-index25.1kcitations405works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bone health and treatments(83), Nanoplatforms for cancer theranostics(73), Photodynamic Therapy Research Studies(45), Bone Metabolism and Diseases(45), TGF-β signaling in diseases(34)

Publications405 total

Near-infrared fatty acid molecular probe for image-guided surgery of glioblastoma
npj Imaging·2025· 4 citedOpen Access
Supplementary Fig. 4 from Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models
2025Open Access
Data from Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models
2025Open Access
Supplementary Fig. 5 from Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models
2025Open Access
Supplementary Fig. 2 from Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models
2025Open Access
Supplementary Fig. 7 from Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models
2025Open Access
Supplementary Fig. 6 from Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models
2025Open Access
Supplementary Fig. 3 from Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models
2025Open Access
Supplementary Fig. 1 from Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models
2025Open Access
Smartphone Imaging for Highly Sensitive Detection of Multicolor Bioluminescence on Organ-on-Chip Platforms
SSRN Electronic Journal·2025Open Access
Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models
Molecular Cancer Therapeutics·2024· 5 citedOpen Access
A Novel Luciferase-Based Reporter Gene Technology for Simultaneous Optical and Radionuclide Imaging of Cells
International Journal of Molecular Sciences·2024Open Access
Rapid Assessment of Bio-distribution and Antitumor Activity of the Photosensitizer Bremachlorin in a Murine PDAC Model: Detection of PDT-induced Tumor Necrosis by IRDye® 800CW Carboxylate, Using Whole-Body Fluorescent Imaging
Molecular Imaging and Biology·2024· 1 citedOpen Access
A fatty-acid based probe for near infrared fluorescence guided surgery of glioblastoma
2024Open Access
Rapid assessment of bio-distribution and antitumor activity of the photosensitizer Bremachlorin in a murine PDAC model: detection of PDT-induced tumor necrosis by IRDye® 800CW Carboxylate, using whole-body fluorescent imaging
2024Open Access
MET-receptor targeted fluorescent imaging and spectroscopy for primary papillary thyroid cancer detection
European Journal of Surgical Oncology·2024
Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging: Erratum
Theranostics·2024· 1 citedOpen Access
MET-receptor targeted fluorescent imaging and spectroscopy to detect multifocal papillary thyroid cancer
European Journal of Nuclear Medicine and Molecular Imaging·2023· 8 citedOpen Access
Applying HDACis to increase SSTR2 expression and radiolabeled DOTA-TATE uptake: from cells to mice
Life Sciences·2023· 3 citedOpen Access
P07.02.B A FATTY-ACID BASED PROBE FOR NEAR INFRARED FLUORESCENCE GUIDED SURGERY OF GLIOBLASTOMA
Neuro-Oncology·2023Open Access
page 1 of 21Next →

Frequent Co-authors

Socrates E. Papapoulos(22), Rutger L. van Bezooijen(11), Peter ten Dijke(9), Gabri van der Pluijm(9), Ivo Que(9), Alexander L. Vahrmeijer(8), Marcel Karperien(6), Merlijn Hutteman(5), Joost R. van der Vorst(5), Cornelis J.�H. van de Velde(5), Geertje van der Horst(5), Herman A. Hamersma(4), J. Sven D. Mieog(4), John V. Frangioni(4), R.L. van Bezooijen(4), Ermond van Beek(4), Jeroen T. Buijs(4), Pieter B. A. A. van Driel(4), L. van der Wee-Pals(3), Martine Deckers(3)